Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) - Plunkett Research

Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)

Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) - Plunkett Research
Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)
Published Aug 14, 2009
71 pages — Published Aug 14, 2009
Price US$ 149.99  |  Buy this Report Now

About This Report

  
Abstract:

This carefully-researched report will be your ready-reference guide to the Biotechnology and Genetics Industry. Excerpted from Plunkett's Biotech and Genetics Industry Almanac, this summary includes our analysis of the major trends, from the convergence of nanotechnology and biotechnology, to the biotech development race among such rising nations as India, Singapore and China, to the medical potential of personalized gene therapy. In addition, we provide statistical tables such as 'Growth in Global Biotechnology: 2007-2008' and 'Biotechnology Financing, U.S., Europe & Canada: 2007-2008.' In one handy summary, you'll get all of the data you need for strategic planning, business development, or industry analysis.

  
Source:
Document ID
1-59392-665-0
Country
Country
Country
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
CONTENTS72
Chapter 1933
The State of the Biotechnology Industry Today94
A Short History of Biotechnology131
Ethanol Production Soared, But a Market Glut May Slow Expansion143
New Money Pours Into Biotech Firms/Mergers and Acquisitions Surge Ahead171
Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms181
From India to Singapore to Australia, Nations Compete Fiercely in Biotech Development182
Medical Trials Conducted Abroad Spark Concerns201
Gene Therapies and Patients Genetic Profiles Promise a Personalized Approach to Medicine202
Breakthrough Drugs for Cancer Treatment Many More Will Follow221
Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues232
Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age251
Biogenerics (Follow-on Biologics) are in Limbo in the U.S.261
Breakthrough Drug Delivery Systems Evolve271
Stem Cells Multiple Sources Stem from New Technologies282
U.S. Government Reverses Ban on Funding for New Stem Cell Research301
Stem Cells Therapeutic Cloning Techniques Advance311
Stem Cells A New Era of Regenerative Medicine Takes Shape321
Nanotechnology Converges with Biotech331
Agricultural Biotechnology ScoresBreakthroughs but Causes Controversy/Selective Breeding Offers a Compromise343
Focus on Vaccines371
Ethical Issues Abound381
Technology Discussion Genomics381
Technology Discussion Proteomics391
Technology Discussion Microarrays391
Technology Discussion DNA Chips391
Technology Discussion SNPs ( Snips )401
Technology Discussion Combinatorial Chemistry401
Technology Discussion Synthetic Biology401
Technology Discussion Recombinant DNA411
Technology Discussion Polymerase Chain Reaction (PCR)411
Chapter 24230
Biotech Industry Overview431
Global Biotechnology at a Glance: 2008441
Growth in Global Biotechnology: 2007-2008451
U.S. Biotechnology at a Glance: 2007-2008461
Biotechnology Financing, U.S., Europe &Canada: 2007-2008471
Quarterly Breakdown of Biotechnology Financings, U.S. &Canada: 2008481
Ernst &Young Survival Index, U.S. &Canadian Biotechnology Companies: 2007-2008491
The U.S. Drug Discovery &Approval Process501
U.S. FDA Approval Times for New Drugs: 1993-2008511
U.S. FDA Approval Times for New Molecular Entities (NMEs): 1993-2008521
U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2008531
Employment in Life &Physical Science Occupations by Business Type, U.S.: May 2008541
Federal R&D &R&D Plant Funding for General Science &Basic Research, U.S.: Fiscal Years 2007-2009551
National Health Expenditure Amounts by Type of Expenditure, U.S.: Selected Calendar Years, 2003-2018561
U.S. Exports &Imports of Pharmaceutical Products: 2003-1st Quarter 2009571
U.S. Prescription Drug Expenditures, Aggregate &Per Capita Amounts, Percent Distribution: Selected Calendar Years, 2003-2018581
Prescription Drug Expenditures, U.S.: 1965-2018592
Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2008611
Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Year 2008-2010621
Global Area of Biotech Crops by Country: 2008631
R&D as a Percentage of U.S. Biopharmaceutical Sales, PhRMA Member Companies: 1970-2008641
Biologics &Biotechnology R&D, PhRMA Member Companies: 2007651
Domestic &Foreign Pharmaceutical Sales, PhRMA Member Companies: 1970-2008661
Sales By Geographic Area, PhRMA Member Companies: 2007671
Domestic Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2007681
R&D by Global Geographic Area, PhRMA Member Companies: 2007691
Domestic Biopharmaceutical R&D Scientific, Professional &Technical Personnel by Function, PhRMA Member Companies: 2007701
Domestic U.S. Biopharmaceutical R&D &R&D Abroad, PhRMA Member Companies: 1970-2008711

Table Of Contents

Plunkett Research—Plunkett Research, Ltd., established in 1985, is a leading provider of business and industry information to the corporate, library, academic and government markets. We specialize in market research that analyzes industry trends, provides competitive intelligence and determines the scope and qualities of market leaders.

About the Author


Cite this Report

  
MLA:
Plunkett Research. "Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)" Aug 14, 2009. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Plunkett-Research/Biotech-Genetics-Industry-Trends-Statistics-Analysis-2010-Summary-2082-422>
  
APA:
Plunkett Research. (2009). Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) Aug 14, 2009. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Plunkett-Research/Biotech-Genetics-Industry-Trends-Statistics-Analysis-2010-Summary-2082-422>
  
US$ 149.99
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.